Jacobio Pharmaceuticals Group Co., Ltd. (HKG:1167)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
6.00
-0.09 (-1.48%)
Feb 13, 2026, 4:08 PM HKT

HKG:1167 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
201.37155.7163.5295.75152.81486.29
Revenue Growth (YoY)
768.54%145.13%-33.66%-37.34%-68.58%-
Cost of Revenue
--60.3283.11139.9844.12
Gross Profit
201.37155.713.212.6312.83442.17
Selling, General & Admin
40.4243.0546.6242.5544.5853.84
Research & Development
246.57330.18372.32445.65280.84185.95
Other Operating Expenses
-8.31-14.33-3.785.36-20.27-7.79
Operating Expenses
278.67358.89415.16493.56305.14232
Operating Income
-77.3-203.19-411.95-480.93-292.31210.17
Interest Expense
-11.08-8.4-8.31-2.27-0.57-0.98
Interest & Investment Income
34.7440.8647.0724.6118.773.83
Currency Exchange Gain (Loss)
3.0512.1920.6982.53-27.26-31.75
Other Non Operating Income (Expenses)
------1,695
EBT Excluding Unusual Items
-50.59-158.53-352.51-376.05-301.38-1,514
Gain (Loss) on Sale of Investments
1.14-0.02-7.244.190.19-
Gain (Loss) on Sale of Assets
-0.13-0.140.63---
Other Unusual Items
3.932.98----
Pretax Income
-45.65-155.71-359.12-371.86-301.19-1,514
Earnings From Continuing Operations
-45.65-155.71-359.12-371.86-301.19-1,514
Minority Interest in Earnings
-----0.02
Net Income
-45.65-155.71-359.12-371.86-301.19-1,514
Net Income to Common
-45.65-155.71-359.12-371.86-301.19-1,514
Shares Outstanding (Basic)
774775773752747381
Shares Outstanding (Diluted)
774775773752747381
Shares Change (YoY)
-0.35%0.26%2.79%0.61%96.13%74.13%
EPS (Basic)
-0.06-0.20-0.46-0.49-0.40-3.97
EPS (Diluted)
-0.06-0.20-0.46-0.49-0.40-3.97
Free Cash Flow
-43.59-86.21-402.03-308.86-157.668.69
Free Cash Flow Per Share
-0.06-0.11-0.52-0.41-0.210.18
Gross Margin
100.00%100.00%5.04%13.20%8.40%90.93%
Operating Margin
-38.39%-130.49%-648.54%-502.29%-191.29%43.22%
Profit Margin
-22.67%-100.00%-565.36%-388.38%-197.10%-311.27%
Free Cash Flow Margin
-21.64%-55.37%-632.92%-322.58%-103.13%14.12%
EBITDA
-67.09-190.69-401.12-473.71-285.57215.91
EBITDA Margin
-33.31%-122.47%---186.88%44.40%
D&A For EBITDA
10.2112.4910.837.216.745.74
EBIT
-77.3-203.19-411.95-480.93-292.31210.17
EBIT Margin
-38.39%-130.49%---191.29%43.22%
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.